Episode Details

The EXTEND-IA TNK trial showed that for acute ischemic stroke, intravenous tenecteplase was as effective as alteplase for achieving good functional outcomes in acute ischemic stroke due to large vessel occlusion--and it may even be superior to alteplase. Dr. Mike Brogan interviews Dr. Bruce Campbell about the results of this pivotal trial.

NCS offers free CE credits for the NCS Podcast Series episodes. Listen to any of the posted episodes, complete a five question survey, and claim your credits here! Credits are available for physicians, pharmacists, nurses, and non-physicians.

The NCS Podcast is the official podcast of the Neurocritical Care Society. Our senior producer is Jim Siegler. Our production staff includes Fawaz Almufti, Becca Stickney, Michael Brogan, Starane Shepherd, Benjamin Miller, and Ramani Balu. Music by Lee Roosevere.

Campbell BCV, Mitchell PJ, Churilov L, et al. Tenecteplase versus Alteplase before Thrombectomy for Ischemic Stroke. The New England journal of medicine. 2018;378:1573-1582.